Results for tag: "Metabolic Drug"

The Metabolic Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market, which focuses on treatments for diseases related to hormones and metabolism. These drugs are used to treat a variety of conditions, including diabetes, obesity, and thyroid disorders. Metabolic drugs are designed to improve the body's ability to process and use energy, as well as to reduce the risk of metabolic diseases. They can also be used to treat conditions such as hyperlipidemia, hyperglycemia, and hypoglycemia. The Metabolic Drug market is highly competitive, with a wide range of products available from various manufacturers. Many of these drugs are available over-the-counter, while others require a prescription. The market is also highly regulated, with strict safety and efficacy standards in place. Some of the major companies in the Metabolic Drug market include Novo Nordisk, Sanofi, Merck, Pfizer, and Eli Lilly. These companies produce a variety of products, including insulin, glucagon-like peptide-1 (GLP-1) agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors. Show Less Read more